Teladoc Health (NYSE:TDOC)'s stock had its "buy" rating reaffirmed by equities research analysts at Piper Sandler in a report released on Tuesday, TipRanks reports. They currently have a $220.00 target price on the health services provider's stock. Piper Sandler's target price would indicate a potential upside of 15.28% from the company's current price.
Other equities analysts have also issued research reports about the company. Cantor Fitzgerald increased their target price on Teladoc Health from $145.00 to $165.00 and gave the company a "neutral" rating in a report on Thursday, April 30th. Cowen increased their target price on Teladoc Health from $175.00 to $197.00 and gave the company an "outperform" rating in a report on Thursday, April 30th. Zacks Investment Research lowered Teladoc Health from a "buy" rating to a "hold" rating and set a $171.00 target price on the stock. in a report on Thursday, May 28th. Barclays reissued a "hold" rating and issued a $180.00 target price (up previously from $140.00) on shares of Teladoc Health in a report on Thursday, April 30th. Finally, KeyCorp increased their target price on Teladoc Health from $180.00 to $195.00 and gave the company an "overweight" rating in a report on Thursday, April 30th. Fifteen analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Teladoc Health currently has an average rating of "Hold" and a consensus target price of $161.58.
Teladoc Health stock opened at $190.84 on Tuesday. Teladoc Health has a twelve month low of $54.58 and a twelve month high of $208.63. The stock's fifty day simple moving average is $179.63 and its 200-day simple moving average is $137.81. The company has a current ratio of 6.14, a quick ratio of 6.14 and a debt-to-equity ratio of 0.45. The firm has a market capitalization of $14.21 billion, a P/E ratio of -141.36 and a beta of 0.44.
Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.40) earnings per share for the quarter, missing analysts' consensus estimates of ($0.35) by ($0.05). Teladoc Health had a negative return on equity of 10.60% and a negative net margin of 16.24%. The company had revenue of $180.80 million for the quarter, compared to analysts' expectations of $180.64 million. During the same period in the prior year, the company posted ($0.43) EPS. The firm's revenue was up 40.6% compared to the same quarter last year. Sell-side analysts predict that Teladoc Health will post -1.12 earnings per share for the current year.
In other news, Director William H. Frist sold 370 shares of the stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $180.00, for a total transaction of $66,600.00. Following the completion of the sale, the director now owns 5,788 shares in the company, valued at $1,041,840. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Adam C. Vandervoort sold 22,516 shares of the firm's stock in a transaction dated Thursday, April 16th. The shares were sold at an average price of $168.83, for a total transaction of $3,801,376.28. Following the completion of the sale, the insider now owns 10,824 shares of the company's stock, valued at approximately $1,827,415.92. The disclosure for this sale can be found here. Insiders have sold 283,958 shares of company stock valued at $48,771,007 in the last quarter. Insiders own 3.42% of the company's stock.
A number of large investors have recently made changes to their positions in TDOC. Capital World Investors lifted its position in Teladoc Health by 510.4% in the first quarter. Capital World Investors now owns 1,403,845 shares of the health services provider's stock valued at $217,610,000 after purchasing an additional 1,173,845 shares during the period. Norges Bank acquired a new stake in Teladoc Health in the fourth quarter valued at about $51,004,000. Renaissance Technologies LLC acquired a new stake in Teladoc Health in the fourth quarter valued at about $45,435,000. Fred Alger Management LLC lifted its position in Teladoc Health by 405.7% in the first quarter. Fred Alger Management LLC now owns 625,931 shares of the health services provider's stock valued at $97,026,000 after purchasing an additional 502,144 shares during the period. Finally, FDx Advisors Inc. lifted its position in Teladoc Health by 16,754.5% in the first quarter. FDx Advisors Inc. now owns 406,531 shares of the health services provider's stock valued at $575,000 after purchasing an additional 404,119 shares during the period. Hedge funds and other institutional investors own 97.66% of the company's stock.
Teladoc Health Company Profile
Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.
See Also: Dead Cat Bounce
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Restaurant Stocks That Still Look Tasty As the Economy Reopens
As part of our national response to the Covid-19 pandemic, many Americans considered it their patriotic, if not moral, duty to support the restaurant industry. And while many consumers were intensely focused on their small, local restaurants, the national chains were still open for business during this time.
And the reality is that the national chains are going to be the most adaptable to whatever pace of economic recovery we see. Hopes for a “V” shaped recovery have pretty much gone out the window. The new model suggests a stair-step recovery may be the best-case scenario.
The worst case scenario for the restaurant industry will be one where different regions of the country are subject to rolling lockdowns. In a business with notoriously low margins, an open/close, open/close recovery would be disastrous.
It’s one reason why I’m not sure I would be diving into restaurant stocks right now. But the same was being said of airline stocks and cruise line stocks. And sure enough, discount investors have been trying to invest in these stocks.
But as all 50 states have now re-opened in some fashion, it’s not unlikely that restaurant stocks are drawing attention from investors. We’ve put together this presentation that highlights seven restaurant stocks that you should consider looking at if you want to dive into this sector.
View the "Restaurant Stocks That Still Look Tasty As the Economy Reopens".